Lotus Pharmaceuticals Stock Price Patterns

LTUS Stock  USD 0  0.00  0.00%   
At this time, the relative strength index (RSI) of Lotus Pharmaceuticals' share price is approaching 45. This indicates that the pink sheet is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Lotus Pharmaceuticals, making its price go up or down.

Momentum 45

 Impartial

 
Oversold
 
Overbought
The successful prediction of Lotus Pharmaceuticals' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Lotus Pharmaceuticals and does not consider all of the tangible or intangible factors available from Lotus Pharmaceuticals' fundamental data. We analyze noise-free headlines and recent hype associated with Lotus Pharmaceuticals, which may create opportunities for some arbitrage if properly timed.
Using Lotus Pharmaceuticals hype-based prediction, you can estimate the value of Lotus Pharmaceuticals from the perspective of Lotus Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Lotus Pharmaceuticals to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying Lotus because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Lotus Pharmaceuticals after-hype prediction price

    
  USD 0.004026  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Lotus Pharmaceuticals Basic Forecasting Models to cross-verify your projections.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Lotus Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intrinsic
Valuation
LowRealHigh
0.00016.73
Details
Naive
Forecast
LowNextHigh
0.000065016.73
Details

Lotus Pharmaceuticals After-Hype Price Density Analysis

As far as predicting the price of Lotus Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Lotus Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Lotus Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Lotus Pharmaceuticals Estimiated After-Hype Price Volatility

In the context of predicting Lotus Pharmaceuticals' pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Lotus Pharmaceuticals' historical news coverage. Lotus Pharmaceuticals' after-hype downside and upside margins for the prediction period are 0.00 and 16.73, respectively. We have considered Lotus Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
0
0
After-hype Price
16.73
Upside
Lotus Pharmaceuticals is out of control at this time. Analysis and calculation of next after-hype price of Lotus Pharmaceuticals is based on 3 months time horizon.

Lotus Pharmaceuticals Pink Sheet Price Outlook Analysis

Have you ever been surprised when a price of a Company such as Lotus Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Lotus Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Lotus Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.76 
16.73
 0.00  
 0.00  
0 Events / Month
0 Events / Month
Uncertain
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
0
0
8.81 
0.00  
Notes

Lotus Pharmaceuticals Hype Timeline

Lotus Pharmaceuticals is now traded for 0. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Lotus is anticipated to increase in value after the next headline, with the price projected to jump to 0.004026 or above. The average volatility of media hype impact on the company the price is insignificant. The price appreciation on the next news is estimated to be 8.81%, whereas the daily expected return is now at 0.76%. The volatility of related hype on Lotus Pharmaceuticals is about 0.0%, with the expected price after the next announcement by competition of 0.00. The company has return on total asset (ROA) of 0.0456 % which means that it generated a profit of $0.0456 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0182 %, meaning that it created $0.0182 on every $100 dollars invested by stockholders. Lotus Pharmaceuticals' management efficiency ratios could be used to measure how well Lotus Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. Given the investment horizon of 90 days the next anticipated press release will be uncertain.
Check out Lotus Pharmaceuticals Basic Forecasting Models to cross-verify your projections.

Lotus Pharmaceuticals Related Hype Analysis

Having access to credible news sources related to Lotus Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Lotus Pharmaceuticals' future price movements. Getting to know how Lotus Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Lotus Pharmaceuticals may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
CDSGChina Dongsheng International 0.00 0 per month 0.00 (0.06) 24.24 (25.00) 78.56 
ALDAAtlantica 0.00 0 per month 0.00  0.11  0.00  0.00  42.86 
AWONA1 Group 0.00 0 per month 12.03  0.02  30.95 (27.50) 85.06 
VNTAVentana Biotech 0.00 0 per month 6.44  0  0.27 (7.75) 75.82 
AAPTAll American Pet 0.00 0 per month 0.00 (0.16) 0.00  0.00  95.00 
MNZOManzo Pharmaceut 0.00 1 per month 0.00  0.00  0.00  0.00  0.00 
HBIEHai Jia International 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
CHMJFChemistree Technology 0.00 0 per month 0.00  0.22  24.00  0.00  96.20 
MYRXMyrexis Cmn Stk 0.00 0 per month 0.00  0.11  0.00  0.00  300.00 
AWWIAlpha Wastewater 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 

Lotus Pharmaceuticals Additional Predictive Modules

Most predictive techniques to examine Lotus price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Lotus using various technical indicators. When you analyze Lotus charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Lotus Pharmaceuticals Predictive Indicators

The successful prediction of Lotus Pharmaceuticals stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Lotus Pharmaceuticals, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Lotus Pharmaceuticals based on analysis of Lotus Pharmaceuticals hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Lotus Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Lotus Pharmaceuticals's related companies.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Lotus Pink Sheet Analysis

When running Lotus Pharmaceuticals' price analysis, check to measure Lotus Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lotus Pharmaceuticals is operating at the current time. Most of Lotus Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Lotus Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lotus Pharmaceuticals' price. Additionally, you may evaluate how the addition of Lotus Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.